Literature DB >> 2577839

Application of continuous-flow liquid chromatography/fast-atom bombardment mass spectrometry to the analysis of diagnostic acylcarnitines in human urine.

D L Norwood1, N Kodo, D S Millington.   

Abstract

Acylcarnitine profiles of diagnostic value were generated from the equivalent of 0.1 microL of raw urine using the continuous-flow liquid chromatography/fast-atom bombardment mass spectrometry (LC/FAB-MS) interface for sample introduction. Further analysis was accomplished by gradient LC/MS using a commercially available packed fused-silica microbore column.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2577839     DOI： 10.1002/rcm.1290021205

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN： 0951-4198            Impact factor:   2.419


  5 in total

1.  Identification of phenylpropionylcarnitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl-CoA dehydrogenase deficiency.

Authors:  R Moore; D S Millington; D Norwood; N Kodo; P Robinson; J F Glasgow
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  The application of normal phase liquid chromatography/mass spectrometry by using coaxial continuous flow fast atom bombardment.

Authors:  D L Lawrence
Journal:  J Am Soc Mass Spectrom       Date:  1992-07       Impact factor: 3.109

3.  A dual-column solid phase extraction strategy for online collection and preparation of continuously flowing effluent streams for mass spectrometry.

Authors:  Jeffrey R Enders; Christina C Marasco; John P Wikswo; John A McLean
Journal:  Anal Chem       Date:  2012-09-25       Impact factor: 6.986

Review 4.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

Review 5.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.